Here’s ChemLex! This AI-for-science startup develops AI technologies that accelerate chemical discovery for the pharmaceutical industry to shorten development time.

Now, they just raised $45M. Oh, and they also established their global headquarters and self-driving laboratory in Singapore.

Investor check. Granite Asia led the round. 

‍

🧪 The ABCs of ChemLex

Founded in 2022, ChemLex has grown to support more than 70 customers worldwide, including six of the world’s top ten pharmaceutical companies. 

They have a 24/7 autonomous chemistry system that accelerates chemical discovery, making it far more cost-efficient and more sustainable than traditional methods. 

• Their fully automated synthesis line runs experiments autonomously, captures data in real-time, and transforms chemical discovery from a stop-start process into a smooth workflow.

‍

Why their tech matters. Their solutions accelerate molecule design and manufacturing at scale, shortening development times and making chemical discovery more efficient.

‍

🧐 What’s with the $$$? 

They’ll use the $$$ to hire more hardware and software engineers and chemists in Singapore. 

Partnered up. ChemLex recently signed a memorandum of understanding with the Experimental Drug Development Centre, Singapore’s national platform for drug discovery and development.

• This collaboration is designed to boost next-generation small molecule drug discovery through advanced automation.